Catch up with the most viewed articles from Frontiers in Oncology this July. All are Open Access – enjoy!
Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)Click to share on LinkedIn (Opens in new window)Click to share on Reddit (Opens in new window)Click to share on Pinterest (Opens in new window)MoreClick to share on WhatsApp (Opens in new window)Click to email a link to a friend (Opens in new window)
Like this:Like Loading…
Pre-clinical models of diffuse intrinsic pontine glioma Katherine L. Misuraca, Francisco J. Cordero and Oren J. Becher*
Dysuria following stereotactic body radiation therapy for prostate cancer Einsley-Marie Janowski, Thomas P. Kole, Leonard N. Chen, Joy S. Kim, Thomas M. Yung, Brian Timothy Collins, Simeng Suy, John H. Lynch, Anatoly Dritschilo and Sean P. Collins*
Overview of methods for overcoming hindrance to drug delivery to tumors, with special attention to tumor interstitial fluid Gianfranco Baronzio*, Gurdev Parmar and Miriam Baronzio
Understanding the key to targeting the IGF axis in cancer: a biomarker assessment Kunal Amratlal Lodhia, Piyawan Tienchaiananda and Paul Haluska*
Range verification methods in particle therapy: underlying physics and Monte Carlo modeling Aafke Christine Kraan*
Spontaneous transformation of murine oviductal epithelial cells: a model system to investigate the onset of fallopian-derived tumors Michael P. Endsley, Georgette Moyle-Heyrman, Subbulakshmi Karthikeyan, Daniel D. Lantvit, David A. Davis, Jian-Jun Wei, and Joanna E. Burdette*
Modeling combined chemotherapy and particle therapy for locally advanced pancreatic cancer Marco Durante*, Francesco Tommasino, and Shigeru Yamada
In vivo effects in melanoma of ROCK inhibition-induced FasL over-expression Iotefa Teiti, Florie Bertrand, Christine Pich, Rémi Gence, Isabelle Lajoie-Mazenc, Philippe Rochaix, Gilles Favre, and Anne-Françoise Tilkin-Mariamé*
HABP2 is a novel regulator of hyaluronan-mediated human lung cancer progression Tamara Mirzapoiazova, Nurbek Mambetsariev, Frances E. Lennon, Bolot Mambetsariev, Joshua E. Berlind, Ravi Salgia, and Patrick A. Singleton*
ROS accumulation by PEITC selectively kills ovarian cancer cells via UPR-mediated apoptosis Yoon-Hee Hong, Md. Hafiz Uddin, Untek Jo, Boyun Kim, Jiyoung Song, Dong Hoon Suh, Hee Seung Kim and Yong Sang Song*
